{
  "trial_id": "NCT03017690",
  "title": "Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)",
  "condition": "Gastroenteropancreatic Neuroendocrine Tumor",
  "participant_count": 22,
  "bias_type": "mixed",
  "age_distribution": {
    "mean": 49.04545454545455,
    "std": 15.382356227733226,
    "min": 18,
    "max": 73
  },
  "gender_distribution": {
    "male": 0.5199193197981377,
    "female": 0.48008068020186234
  },
  "ethnicity_distribution": {
    "white": 0.7,
    "black": 0.15,
    "asian": 0.1,
    "hispanic": 0.04,
    "other": 0.01
  },
  "sample_size": 22,
  "eligibility_score": 0.8317472549708719
}